LIFE Study: Least Invasive Fast-Track EVAR
view all Clinical Trials
The LIFE Study is a prospective, consecutively enrolling, non-randomized multi center post-market registry to evaluate the ultra low profile (14F) Ovation Abdominal Stent Graft Platform when using in the Percutaneous Endovascular Aneurysm Repair (P-EVAR) treatment of patients with AAA using a Fast-Track EVAR protocol.
250 study patients will be enrolled at up to 40 institutions. Follow-up period is one month.
For more information about this trial or to inquire about eligibility, call Arrikka Mullins, MPH at 215-707-3622.